P Sati1, D M Thomasson2, N Li3, D L Pham3, N M Biassou4, D S Reich5, J A Butman6. 1. Translational Neuroradiology Unit, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA satip@ninds.nih.gov. 2. Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. 3. Center for Neuroscience and Regenerative Medicine at the Uniformed Services University of the Health Sciences and the National Institutes of Health, Bethesda, MD, USA. 4. Radiology and Imaging Sciences, Department of Diagnostic Radiology, Clinical Center, National Institutes of Health, Bethesda, MD, USA. 5. Translational Neuroradiology Unit, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA Radiology and Imaging Sciences, Department of Diagnostic Radiology, Clinical Center, National Institutes of Health, Bethesda, MD, USA. 6. Center for Neuroscience and Regenerative Medicine at the Uniformed Services University of the Health Sciences and the National Institutes of Health, Bethesda, MD, USA Radiology and Imaging Sciences, Department of Diagnostic Radiology, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Abstract
BACKGROUND: Susceptibility-based MRI offers a unique opportunity to study neurological diseases such as multiple sclerosis (MS). In this work, we assessed a three-dimensional segmented echo-planar-imaging (3D-EPI) sequence to rapidly acquire high-resolution T2 -weighted and phase contrast images of the whole brain. We also assessed if these images could depict important features of MS at clinical field strength, and we tested the effect of a gadolinium-based contrast agent (GBCA) on these images. MATERIALS AND METHODS: The 3D-EPI acquisition was performed on four healthy volunteers and 15 MS cases on a 3T scanner. The 3D sagittal images of the whole brain were acquired with a voxel size of 0.55 × 0.55 × 0.55 mm(3) in less than 4 minutes. For the MS cases, the 3D-EPI acquisition was performed before, during, and after intravenous GBCA injection. RESULTS: Both T2-weighted and phase-contrast images from the 3D-EPI acquisition were sensitive to the presence of lesions, parenchymal veins, and tissue iron. Conspicuity of the veins was enhanced when images were obtained during injection of GBCA. CONCLUSIONS: We propose this rapid imaging sequence for investigating, in a clinical setting, the spatiotemporal relationship between small parenchymal veins, iron deposition, and lesions in MS patient brains.
BACKGROUND: Susceptibility-based MRI offers a unique opportunity to study neurological diseases such as multiple sclerosis (MS). In this work, we assessed a three-dimensional segmented echo-planar-imaging (3D-EPI) sequence to rapidly acquire high-resolution T2 -weighted and phase contrast images of the whole brain. We also assessed if these images could depict important features of MS at clinical field strength, and we tested the effect of a gadolinium-based contrast agent (GBCA) on these images. MATERIALS AND METHODS: The 3D-EPI acquisition was performed on four healthy volunteers and 15 MS cases on a 3T scanner. The 3D sagittal images of the whole brain were acquired with a voxel size of 0.55 × 0.55 × 0.55 mm(3) in less than 4 minutes. For the MS cases, the 3D-EPI acquisition was performed before, during, and after intravenous GBCA injection. RESULTS: Both T2-weighted and phase-contrast images from the 3D-EPI acquisition were sensitive to the presence of lesions, parenchymal veins, and tissue iron. Conspicuity of the veins was enhanced when images were obtained during injection of GBCA. CONCLUSIONS: We propose this rapid imaging sequence for investigating, in a clinical setting, the spatiotemporal relationship between small parenchymal veins, iron deposition, and lesions in MS patient brains.
Authors: E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus Journal: Magn Reson Imaging Date: 2005-01 Impact factor: 2.546
Authors: David Pitt; Aaron Boster; Wei Pei; Eric Wohleb; Adam Jasne; Cherian R Zachariah; Kottil Rammohan; Michael V Knopp; Petra Schmalbrock Journal: Arch Neurol Date: 2010-07
Authors: Emma C Tallantyre; Paul S Morgan; Jennifer E Dixon; Ali Al-Radaideh; Matthew J Brookes; Nikos Evangelou; Peter G Morris Journal: Invest Radiol Date: 2009-09 Impact factor: 6.016
Authors: J D Dworkin; P Sati; A Solomon; D L Pham; R Watts; M L Martin; D Ontaneda; M K Schindler; D S Reich; R T Shinohara Journal: AJNR Am J Neuroradiol Date: 2018-09-13 Impact factor: 3.825
Authors: Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban Journal: Nat Rev Neurol Date: 2015-07-07 Impact factor: 42.937
Authors: E S Beck; P Sati; V Sethi; T Kober; B Dewey; P Bhargava; G Nair; I C Cortese; D S Reich Journal: AJNR Am J Neuroradiol Date: 2018-02-08 Impact factor: 3.825
Authors: M I Gaitán; P Yañez; M E Paday Formenti; I Calandri; E Figueiredo; P Sati; J Correale Journal: AJNR Am J Neuroradiol Date: 2020-02-13 Impact factor: 3.825
Authors: Ilena C George; Pascal Sati; Martina Absinta; Irene Cm Cortese; Elizabeth M Sweeney; Colin D Shea; Daniel S Reich Journal: Mult Scler Date: 2016-01-14 Impact factor: 6.312